Enzychem Lifesciences Corporation (KOSDAQ:183490)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Raw Drug Product Division			34.18B	25.63B	21.60B	24.99B	31.22B
Raw Drug Product Division Growth			33.36%	18.64%	-13.54%	-19.97%	4.68%
Health Functional Food Division			930.87M	1.01B	1.37B	831.28M	446.50M
Health Functional Food Division Growth			-7.58%	-26.55%	64.96%	86.18%	-63.01%
Bio-Maintenance Sector			40.93B	-	-	-	-
Adjustment and Removal			-	-	-	-	-199.22M
Total			76.04B	26.64B	22.98B	25.82B	31.47B
Total Growth			185.46%	15.94%	-11.01%	-17.96%	1.40%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
South Korea			70.91B	23.87B	21.87B	23.72B	28.37B
South Korea Growth			197.08%	9.15%	-7.82%	-16.38%	11.11%
Overseas			5.13B	2.77B	1.11B	2.10B	3.10B
Overseas Growth			85.30%	149.76%	-47.10%	-32.34%	-43.66%
Total			76.04B	26.64B	22.98B	25.82B	31.47B
Total Growth			185.46%	15.94%	-11.01%	-17.96%	1.40%

Source: S&P Global Market Intelligence.